Skip to main content
. 2021 Sep 14;16(9):e0257397. doi: 10.1371/journal.pone.0257397

Fig 2. Renal outcomes of IC-MPGN and C3GN.

Fig 2

Significant differences were observed in serum creatinine elevations of 50% (sCr × 1.5, A) and end-stage kidney disease (ESKD) (B) between IC-MPGN and C3GN patients. Kaplan-Meier curves for treated and untreated patients analyzed using log-rank tests. IC-MPGN, immune-complex membranoproliferative glomerulonephritis; C3GN, C3 glomerulonephritis.